Lista de obras - Roberto Alvarez-Lafuente

Abnormal transforming growth factor-beta expression in mesenchymal stem cells from patients with osteoarthritis

scientific article published on 01 April 2008

Active human herpesvirus 6 infection in patients with multiple sclerosis

scientific article published on 01 June 2002

Adaptive Features of Natural Killer Cells in Multiple Sclerosis

scientific article published on 15 October 2019

Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.

artículo científico publicado en 2015

Alternative splicing and proteolytic rupture contribute to the generation of soluble IL-6 receptors (sIL-6R) in rheumatoid arthritis.

artículo científico publicado en 2013

Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis

artículo científico publicado en 2014

Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission

artículo científico publicado en 2004

Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

artículo científico publicado en 2017

CD46 expression and HHV-6 infection in patients with multiple sclerosis.

artículo científico publicado en 2009

CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatment

scientific article published on 21 December 2010

Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients ⬇️

artículo científico publicado el 29 de abril de 2013

Classification of HHV-6A and HHV-6B as distinct viruses.

artículo científico publicado en 2013

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

artículo científico publicado en 2017

Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA

artículo científico publicado en 2007

Epidemiology of multiple sclerosis and vitamin D levels in Lanzarote, Canary Islands, Spain

artículo científico publicado en 2019

Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients.

artículo científico publicado en 2013

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

artículo científico publicado en 2016

HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.

artículo científico publicado en 2014

HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis

artículo científico publicado en 2014

Herpesvirus active replication in multiple sclerosis

artículo científico publicado en 2011

Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients.

artículo científico publicado en 2008

Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis

artículo científico publicado en 2014

Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients

scientific article published on 25 April 2011

Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study.

artículo científico publicado en 2006

Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive

artículo científico publicado en 2007

Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction

artículo científico publicado en 2005

IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosis

scientific article published on 01 September 2011

Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis.

artículo científico publicado en 2014

Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.

artículo científico publicado en 2014

JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event.

artículo científico publicado en 2007

JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab

artículo científico publicado en 2016

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

scientific article published on 08 May 2019

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

artículo científico publicado en 2015

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the ‘hygiene hypothesis’?

MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.

artículo científico publicado en 2012

MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients

artículo científico publicado en 2009

Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition

article

Metabolomic signatures associated with disease severity in multiple sclerosis

artículo científico publicado en 2017

Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.

artículo científico publicado en 2015

Multicenter Comparison of PCR Assays for Detection of Human Herpesvirus 6 DNA in Serum.

artículo científico publicado en 2009

Multimarker risk stratification approach at multiple sclerosis onset.

artículo científico publicado en 2017

Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertion

artículo científico publicado en 2015

Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome

artículo científico publicado en 2018

Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study

scientific article published on 09 May 2019

Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study

artículo científico publicado en 2009

New life to an old treatment: pegylated Interferon beta 1a in the management of multiple sclerosis

artículo científico publicado en 2018

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.

artículo científico publicado en 2015

Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction

artículo científico publicado en 2005

Prevalence of herpesvirus DNA in MS patients and healthy blood donors

artículo científico publicado en 2002

Real-time polymerase chain reaction detection of Neisseria meningitidis in formalin-fixed tissues from sudden deaths.

artículo científico publicado en 2008

Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection.

artículo científico publicado en 2004

Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis.

artículo científico publicado en 2013

Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients.

artículo científico publicado en 2004

Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort.

artículo científico publicado en 2016

Study of the possible link of 25-hydroxyvitamin D with Epstein-Barr virus and human herpesvirus 6 in patients with multiple sclerosis

artículo científico publicado en 2018

Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients

article

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity

artículo científico publicado en 2013

Toll‐like receptor‐9 in Spanish multiple sclerosis patients: an association with the gender ⬇️

artículo científico publicado el 4 de junio de 2013

Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.

artículo científico publicado en 2017

Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.

artículo científico publicado en 2010

Virological analysis in the diagnosis of sudden children death: a medico-legal approach.

artículo científico publicado en 2005

[Evaluation of diagnostic techniques of active cytomegalovirus infection (response)]

artículo científico publicado en 1998

Lista de obras de Roberto Alvarez-Lafuente

Abnormal transforming growth factor-beta expression in mesenchymal stem cells from patients with osteoarthritis

Active human herpesvirus 6 infection in patients with multiple sclerosis

Adaptive Features of Natural Killer Cells in Multiple Sclerosis

Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.

Alternative splicing and proteolytic rupture contribute to the generation of soluble IL-6 receptors (sIL-6R) in rheumatoid arthritis.

Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis

Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission

Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

CD46 expression and HHV-6 infection in patients with multiple sclerosis.

CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatment

Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients ⬇️

Classification of HHV-6A and HHV-6B as distinct viruses.

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA

Epidemiology of multiple sclerosis and vitamin D levels in Lanzarote, Canary Islands, Spain

Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.

HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis

Herpesvirus active replication in multiple sclerosis

Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients.

Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis

Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients

Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study.

Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive

Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction

IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosis

Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis.

Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.

JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event.

JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the ‘hygiene hypothesis’?

MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.

MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients

Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition

Metabolomic signatures associated with disease severity in multiple sclerosis

Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.

Multicenter Comparison of PCR Assays for Detection of Human Herpesvirus 6 DNA in Serum.

Multimarker risk stratification approach at multiple sclerosis onset.

Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertion

Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome

Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study

Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study

New life to an old treatment: pegylated Interferon beta 1a in the management of multiple sclerosis

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.

Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction

Prevalence of herpesvirus DNA in MS patients and healthy blood donors

Real-time polymerase chain reaction detection of Neisseria meningitidis in formalin-fixed tissues from sudden deaths.

Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection.

Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis.

Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients.

Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort.

Study of the possible link of 25-hydroxyvitamin D with Epstein-Barr virus and human herpesvirus 6 in patients with multiple sclerosis

Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity

Toll‐like receptor‐9 in Spanish multiple sclerosis patients: an association with the gender ⬇️

Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.

Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.

Virological analysis in the diagnosis of sudden children death: a medico-legal approach.

[Evaluation of diagnostic techniques of active cytomegalovirus infection (response)]